about
Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's diseaseMultiple system atrophy: the case for an international collaborative effortCognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group.Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease.Intact olfaction in a mouse model of multiple system atrophy.Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management.New insights into atypical parkinsonism.Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative.An update on the cerebellar subtype of multiple system atrophy.Interventional trials in atypical parkinsonism.Toward disease modification in multiple system atrophy: Pitfalls, bottlenecks, and possible remedies.Which ante mortem clinical features predict progressive supranuclear palsy pathology?Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System AtrophyNew insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study.Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism.Multiple system atrophy: insights into a rare and debilitating movement disorder.Multiple system atrophy in the USA: another piece in the jigsaw.Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy.[MSA-QoL: disease-specific questionnaire to assess health-related quality of life in multiple system atrophy: validation of the German translation].Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study.Brain structural profile of multiple system atrophy patients with cognitive impairment.Key themes and future prospects in translational multiple system atrophy research.Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism.Autonomic failure in CANVAS syndrome.Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.Sex and age effects on cardiovascular autonomic function in healthy adults.Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson's Disease: A Cross-Sectional StudyStructural Imaging in Atypical ParkinsonismDiagnosis of PSP-P: Can a newly developed MRPI make the difference?The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonismOrthostatic hypotension is differentially associated with the cerebellar versus the parkinsonian variant of multiple system atrophy: a comparative studyThe Unified Multiple System Atrophy Rating Scale: intrarater reliabilityNeurodegenerative disease: Multiple system atrophy-new insight from prospective studiesMultiple system atrophyRifampicin for multiple system atrophy1.5 Versus 3 tesla magnetic resonance planimetry in neurodegenerative parkinsonismAutomated MRI Classification in Progressive Supranuclear Palsy: a Large International Cohort StudyAbnormalities on structural MRI associate with faster disease progression in multiple system atrophyA critique of the second consensus criteria for multiple system atrophy
P50
Q28071861-B6FBCE90-B10B-47D1-8452-35F8E88A459AQ28647285-D046E745-72FD-44FB-8698-9275ED2E6907Q34245237-79208727-3CDE-4190-A12A-FC0F4CC5605DQ34550489-62F9236E-E025-49A2-B7C3-3832666C9163Q34732028-BF72ADC9-BF0C-459D-B3CC-5AFBDA7A9715Q37150169-0FB2E659-1F83-4801-928D-640A5EC8615DQ37876156-05FD05BD-9E17-4EFA-AB00-8DF31261E321Q38486351-B8850110-8007-4B39-AD62-DDC891A2E952Q38578814-D70DCCAD-8F13-4F9B-9ED1-B72DDD12EF35Q38595613-D2C279D5-0080-4550-8859-8CA98DE70374Q38712697-69F9DDDC-EF3A-4334-BF4F-264B65BDAB40Q38788274-FAA6AFE5-E95B-4752-B5E2-44BC37FF9070Q38809733-3DB99514-14A7-4AB2-A9B1-9C50BF0B8BF9Q39006423-28D8DE21-AC02-457C-B2C5-1AF2401FD6CEQ39150852-7138B6BD-2A35-4872-B24C-ACA3ABD15AD8Q39183459-8FF0A7DD-8519-4463-9D31-1540C569BAFCQ41706869-842285C5-3821-48DD-8ACA-23652325A004Q42132275-016DCEF7-10F4-48AC-BE5C-E673CE452F5CQ43671154-E29080D2-314C-4163-B047-FD000D3947BBQ47119321-6364C19F-6737-4C40-BCB6-D7741AC65759Q47902364-8DE554F9-E41E-4A57-9E2C-DA207BFC63E4Q47967051-858E14C9-257E-4485-89D6-D10EBB9E803AQ48279155-099B78B3-5EB4-4C2A-8FA1-7D2667868168Q48546716-D3D05FF8-12D1-4747-9FE3-0896F8B48AB4Q48550721-2F8BF342-177A-41CA-A6D3-1E26D4E382AAQ50573629-982D21AE-7394-4F24-80F8-177AE5789E7CQ57158979-8086B2EF-8FED-4E53-92DF-6A587EB7F101Q58580478-6C4BDFB6-C1A2-41CC-A806-A858670BEA5EQ64859907-8BA42CAD-2156-422D-ABA4-95EF69A43025Q64900495-15A96819-4EFD-4C03-AC1A-A72918178063Q84710568-85F393AE-54AD-4B42-952C-2FD734E4C460Q85327676-34BEC398-26AB-440C-A173-E777CD5D2DE2Q85635789-E74285BE-8665-44C6-BD28-504F4D3DD38FQ86455072-CAB0E2CD-9B9E-4BB1-A8BE-B5A6B9D1B0CCQ87252837-552B4A8B-518D-4191-BD8C-4B0569EED92AQ88623281-86BC4608-D441-4328-A42F-541FF6AF38DBQ89857896-FE44D9A1-33D4-4BA4-B22F-A64C845E9E0CQ91140740-362B5D5D-16B2-4F9C-8762-7AECB242C934Q91605456-E367129A-8C80-4320-957C-FB84930177C4
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Florian Krismer
@ast
Florian Krismer
@en
Florian Krismer
@es
Florian Krismer
@nl
Florian Krismer
@sl
type
label
Florian Krismer
@ast
Florian Krismer
@en
Florian Krismer
@es
Florian Krismer
@nl
Florian Krismer
@sl
prefLabel
Florian Krismer
@ast
Florian Krismer
@en
Florian Krismer
@es
Florian Krismer
@nl
Florian Krismer
@sl
P106
P1153
56589781100
P21
P31
P496
0000-0002-4493-5073